Generally, 11q-deletion and MYCN amplification do not co-exist in the same tumor, although rare cases that harbor both 11q deletion and MYCN amplification have been described and constitute a very high-risk group of neuroblastoma patients (Table 1 [21]). Here, MYCN is linked to neuroblastoma.